stars 1 stars 2 stars 3

ProKidney, a pioneer in the treatment of chronic kidney disease through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, rilparencel (also known as REACT®), is a first-in-class, patented, proprietary autologous cellular therapy being evaluated in Phase 2 and Phase 3 studies for its potential to preserve kidney function in diabetic patients at high risk of kidney failure. Rilparencel has received Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA. For more information, please visit www.prokidney.com.

ProKidney Corp. Questions

The ProKidney Corp. annual revenue was $154 million in 2026.

Bruce Culleton is the CEO of ProKidney Corp..

185 people are employed at ProKidney Corp..

ProKidney Corp. is based in Winston-Salem, North Carolina.

The NAICS codes for ProKidney Corp. are [54, 541].

The SIC codes for ProKidney Corp. are [873, 87].

Top ProKidney Corp. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users